Source: CompanyNews HQ

ArchiMed: Bird & Bird Advises ArchiMed in Three Acquisitions

Bird & Bird represented ArchiMed, a European healthcare-focused private equity fund, in three simultaneous acquisitions that will create an innovativeView post on CompanyNewsHQ: Bird & Bird Advises ArchiMed in Three Acquisitions

Read full article »
ArchiMed's Competitors | ArchiMed's News | ArchiMed's Financials
Stay up-to-date with the latest news on ArchiMed
Est. Annual Revenue
$25-100M
Est. Employees
25-100
Denis RIBON's photo - Chairman & CEO of ArchiMed

Chairman & CEO

Denis RIBON

CEO Approval Rating

90/100

Read more
Stay up-to-date with the latest news on ArchiMed